News

Controlling DSIFprotein can help researchers to discover new methods for controlling inflammation, and immune responses, as well as the cell cycle processes that can lead to cancer. Activity

The companies are planning to submit Ruconest biologics license application (BLA) within the first six months of 2013 to the FDA. Upon the acceptance of BLA for FDA

The selected candidate, CAM-1, was effective against all tested MRSA along with hospital and community acquired MRSA strains than current standard antibiotics. Mode of action of the new

The lab, which was temporarily shut down for revision, has again resumed operations to serve stem cell banking customers. The GTP Centre I, which has been initially completed

Along with the Repligen’s enhanced bioprocessing products, the company also offers protein A, growth factor products for cell culture fermentation as well as OPUS pre-packed chromatography columns for

The council in its representation has also sought omission of the merchant exporters from bar coding completely as the industry is mainly made up of small scale and

Somatoprim, the somatostatin analog (SSA) based on a novel amino acid composition, demonstrated significant receptor binding and pharmacological profile compared to currently marketed SSAs. Aspireo CEO Carsten Dehning

Absoricais, which is licensed from Cipher Pharmaceuticals, can be given without regards to meals. Formulated using patented Lidose technology, the product’s fasted Area under the plasma/serum/blood concentration-time curve

The company has neither revealed the reasons for the call back nor mentioned the facility from where the recalled products were manufactured. The Business Today cited Ranbaxy’s BSE